- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Dihydropyrimidine Induced Gastrointestinal Toxicity in Colorectal Cancer in Australia
Total 193 results
-
Carina Biotech LimitedRecruitingColorectal Cancer MetastaticAustralia
-
The Queen Elizabeth HospitalNovartis; AmgenCompletedColorectal Cancer | Colorectal Tumors | Colorectal Carcinoma | Neoplasms, ColorectalAustralia
-
Novartis PharmaceuticalsTerminated
-
Austin HealthUnknownMetastatic Colorectal CancerAustralia
-
University of SydneyCompletedColorectal Cancer ScreeningAustralia
-
Hoffmann-La RocheCompletedBreast Cancer, Colorectal CancerNew Zealand, Australia, United Kingdom
-
Austin HealthRoyal North Shore Hospital; Ballarat Health Services; Queen Elizabeth Hospital...UnknownMetastatic Colorectal CancerAustralia
-
Australasian Gastro-Intestinal Trials GroupCompletedMetastatic Colorectal CancerAustralia, New Zealand
-
Australasian Gastro-Intestinal Trials GroupOlivia Newton-John Cancer Research InstituteRecruiting
-
Western General Hospital, AustraliaMerck Serono International SA; Alchemia OncologyUnknown
-
Alchemia OncologyUnknown
-
Bionomics LimitedCPR Pharma Services Pty Ltd, AustraliaTerminatedColorectal CancerAustralia
-
OncoMed Pharmaceuticals, Inc.Novotech (Australia) Pty LimitedCompletedColorectal CancerAustralia, New Zealand
-
Austrian Society Of Surgical OncologyCompletedMetastatic Colorectal CancerAustria
-
Klinikum FloridsdorfMedical University of Vienna; Klinik Favoriten; Salzkammergut Klinikum VöcklabruckCompletedThe Aim of This Study is to Determine the Influence of BMI and Lymph Node Status on OS in CRC Patients in the Long TermAustria
-
KU LeuvenUnknownMetastatic Colorectal CancerKorea, Republic of, Spain, Austria, Denmark, United States, Australia, Germany, Netherlands, Belgium, Brazil, Estonia, Greece, Italy, Norway, Romania, Russian Federation, South Africa, Sweden, United Kingdom
-
Medical University of ViennaTerminated
-
AUM Biosciences Pte LtdMerck Sharp & Dohme LLCRecruitingMetastatic Colorectal CancerAustralia
-
Arbeitsgemeinschaft medikamentoese TumortherapieCompleted
-
Australasian Gastro-Intestinal Trials GroupCompleted
-
Novartis PharmaceuticalsCompletedMetastatic Colorectal CancerSpain, Italy, Singapore, Canada, Israel, Korea, Republic of, Netherlands, Australia
-
Prof. Dr. Werner ScheithauerCompletedMetastatic Colorectal CancerAustria
-
Eli Lilly and CompanyCompletedColorectal CancerAustralia, Germany, Greece, Netherlands, Spain
-
Targovax ASATerminated
-
Hoffmann-La RocheCompletedBreast Cancer, Colorectal Cancer, Gastric CancerAustria
-
K-Group, Beta, Inc., a wholly owned subsidiary...PfizerRecruitingMetastatic Colorectal CancerSpain, Australia, United States, Italy, Germany, Poland, Hungary
-
University Health Network, TorontoUniversity College London Hospitals; Brigham and Women's Hospital; University... and other collaboratorsRecruitingHeart Failure | Cancer | Cardiotoxicity | Cardiac Toxicity | Antineoplastics ToxicityCanada, United States, United Kingdom, Australia
-
Celgene CorporationTerminatedColorectal CancerAustralia, Belgium, Germany, Italy, Spain, Sweden
-
Boston Scientific CorporationBiocompatibles UK LtdCompletedMetastatic Colorectal CancerUnited Kingdom, Austria, France
-
Arbeitsgemeinschaft medikamentoese TumortherapieMerck Sharp & Dohme LLCCompleted
-
Trans Tasman Radiation Oncology GroupCompleted
-
Peter MacCallum Cancer Centre, AustraliaCompleted
-
Hoffmann-La RocheCompletedColorectal CancerCanada, Australia, New Zealand
-
Klinik FavoritenCompletedGastrointestinal NeoplasmAustria
-
Cabrini HealthCompletedColon Cancer | Model DiseaseAustralia
-
Arbele Pty LtdRecruitingGastric Cancer | Pancreatic Cancer | Cholangiocarcinoma | Esophageal Adenocarcinoma | Gastrointestinal Cancer | Liver Cancer | Colorectal Adenocarcinoma | Gastroesophageal JunctionHong Kong, Australia
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedColorectal CancerUnited States, Australia
-
Genentech, Inc.Active, not recruitingColorectal CancerSpain, United States, Australia, Canada
-
Bristol-Myers SquibbActive, not recruitingMicrosatellite Stable Colorectal Cancer | Mismatch Repair Proficient Colorectal Cancer | Microsatellite Unstable Colorectal Cancer | Mismatch Repair Deficient Colorectal CancerUnited States, Australia, Belgium, Canada, Ireland, Italy, Spain, France
-
Novartis PharmaceuticalsActive, not recruitingMetastatic Colorectal CancerCanada, Taiwan, Belgium, Germany, Spain, Italy, Czechia, Switzerland, Australia, United States, Japan, Singapore, United Kingdom, France, Israel, Hong Kong, Korea, Republic of
-
Hoffmann-La RocheTerminatedColorectal CancerUnited States, Spain, United Kingdom, Australia, Belgium, France, Austria
-
Array BioPharmaCompletedMetastatic Colorectal CancerUnited States, Australia, Belgium, Canada, France, Israel, Italy, Netherlands, Singapore, Spain
-
Novartis PharmaceuticalsActive, not recruitingBRAF V600 Colorectal CancerBelgium, Germany, Netherlands, Spain, Singapore, Australia, United Kingdom, Israel, Canada, United States
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedMetastatic Colorectal CancerAustria, France, Hungary, United Kingdom, Italy, Germany, Spain
-
Genentech, Inc.CompletedMetastatic Colorectal CancerBelgium, United States, Spain, Australia, Poland
-
Janssen Research & Development, LLCTerminatedMetastatic Colorectal CancerUnited States, Spain, Australia, Belgium, Israel, Austria, Czechia, United Kingdom, Hungary, Italy, Netherlands, Poland, Switzerland
-
BeiGeneRecruitingUnresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal CancerChina, United States, Australia, Puerto Rico
-
Gilead SciencesActive, not recruitingMetastatic Colorectal CancerUnited States, Spain, Australia, Hong Kong, France, Belgium, Canada, Puerto Rico, Germany, Italy
-
MedImmune LLCTerminatedMetastatic Microsatellite-stable Colorectal CancerUnited States, Spain, France, Australia, Canada
-
Austrian Breast & Colorectal Cancer Study GroupMerck Gesellschaft mbH, AustriaTerminatedColorectal Cancer | SteatohepatitisAustria